Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

“In vitro” improvement of defective monocyte chemotaxis in intravenous drug abusers after incubation with ascorbic acid

Summary

Intravenous drug abusers have a deficit of monocyte chemotaxis. “In vitro” ascorbic acid restores the impaired chemotaxis.

This is a preview of subscription content, log in to check access.

Abbreviations

CI:

Chemotactic index

EAS:

Endotoxin-activating serum

IDA:

Intravenous drug abusers

PBM:

Peripheral blood monocytes

References

  1. 1.

    Boxer LA, Watanave AM, Rister M et al. (1976) Correction of leukocyte function in Chediak-Higashi syndrome by ascorbate. N Engl J Med 295:1041–1045

  2. 2.

    Brown SM, Stimmel B, Taub RN, Koch WAS, Rosenfield R (1974) Immunologic dysfunction in heroin addicts. Arch Intern Med 134:1001–1006

  3. 3.

    Cherubin CE (1971) Infectious disease problems of narcotic addicts. Arch Intern Med 128:309–313

  4. 4.

    Gallin JI, Sandler JA, Clyman RI, Manganiello VC, Vaughan M (1978) Agents that increase cyclic AMP inhibit accumulation of cGMP and depress human monocyte locomotion. J Immunol 120:492–496

  5. 5.

    Poli G, Bottazi B, Acero R et al. (1985) Monocyte function in intravenous drug abusers with lymphadenopathy syndrome and in patients with acquired immunodeficiency syndrome: selective impairment of chemotaxis. Clin Exp Immunol 62:136–142

  6. 6.

    Poli G, Introna M, Zanaboni F et al. (1985) Natural killer cells in intravenous drug-abusers with lymphadenopathy syndrome. Clin Exp Immunol 62:128–135

  7. 7.

    Snyderman R, Altman LC, Harsman Ms, Mergenhager SH (1972) Human mononuclear leucocyte chemotaxis: a quantitative assay for humoral and cellular chemotactic factors. J Immunol 108:857–860

Download references

Author information

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Lopez, A.J., Palomo, D.G., Castrillon, J.L.P. et al. “In vitro” improvement of defective monocyte chemotaxis in intravenous drug abusers after incubation with ascorbic acid. Klin Wochenschr 65, 625–626 (1987). https://doi.org/10.1007/BF01726674

Download citation

Key words

  • Monocyte
  • Chemotaxis
  • Ascorbic acid
  • Intravenous drug abusers